Prevalence and Incidence of Problematic Prescription Opioid Use and Abuse in the United Kingdom and Germany (OXY9504)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/17996
• EU PAS number:
  EUPAS10129
• Study ID:
  17996
• Official title and acronym:
  Prevalence and Incidence of Problematic Prescription Opioid Use and Abuse in the United Kingdom and Germany (OXY9504)
• DARWIN EU® study:
  No
• Study countries:
  Germany

  United Kingdom
• Study status:
  Finalised

Research institution and networks

Institutions

Real World Evidence Solutions, IMS Health

France

Study timelines

Date when funding contract was signed

Planned: 11/11/2013

Actual: 02/12/2013

Study start date

Planned: 11/03/2014

Actual: 08/04/2014

Data analysis start date

Planned: 25/05/2015

Date of final study report

Planned: 25/05/2016

Actual: 27/06/2016

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Mundipharma Research Ltd

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable